Association of Smoking with DsDNA Autoantibody Production in Systemic Lupus Erythematosus

Overview

Journal Ann Rheum Dis

Specialty Rheumatology

Date 2005 Sep 10

PMID 16150789

Citations 55

Authors

M M Freemer

T E King Jr

L A Criswell

Affiliations

Soon will be listed here.

Abstract

Objective: To determine whether exposure to tobacco smoke is associated with double stranded DNA (dsDNA) seropositivity in patients with systemic lupus erythematosus (SLE).

Methods: Medical record review was used to confirm the diagnosis of SLE and evaluate dsDNA antibody status. Smoking status at the time of autoantibody testing was assessed by patients' questionnaire responses. Multivariate regression analysis was used to determine whether exposure to tobacco smoke is associated with dsDNA seropositivity, while controlling for sex and age at SLE diagnosis.

Results: A significantly higher risk of dsDNA seropositivity in current smokers than never smokers (odds ratio (OR) = 4.0, 95% confidence interval (CI) 1.6 to 10.4) was shown by multivariate analysis. Current smokers were found to be at higher risk for dsDNA seropositivity than former smokers (OR = 3.0, 95% CI 1.3 to 7.1). The association between current smoking and dsDNA seropositivity remained significant after adjustment for sex, age at SLE diagnosis, amount smoked, age when smoking began, and the duration of smoking cessation (for former smokers).

Conclusion: The association of smoking with dsDNA seropositivity provides insight into the potential mechanisms underlying autoantibody formation. This information may also serve as a possible point of intervention to prevent disease or target treatment.

Citing Articles

Breaking research silos to achieve equitable precision medicine in rheumatology.

Ainsworth H, Baker Frost D, Lim S, Ramos P Nat Rev Rheumatol. 2025; 21(2):98-110.

PMID: 39794514 PMC: 11910143. DOI: 10.1038/s41584-024-01204-7.

Anxiety and Depression and Associated Risk Factors among Outpatients with Systemic Lupus Erythematosus: Eastern Province, Saudi Arabia.

Hasan M, Almogaliq W, Alhanabi F, Aldrazi H, Alkhouzaie M, Albukhari R Clin Pract. 2024; 14(2):486-497.

PMID: 38525716 PMC: 10961743. DOI: 10.3390/clinpract14020037.

PheWAS and cross-disorder analysis reveal genetic architecture, pleiotropic loci and phenotypic correlations across 11 autoimmune disorders.

Topaloudi A, Jain P, Martinez M, Bryant J, Reynolds G, Zagoriti Z Front Immunol. 2023; 14:1147573.

PMID: 37809097 PMC: 10552152. DOI: 10.3389/fimmu.2023.1147573.

Serum antinuclear autoantibodies are associated with measures of oxidative stress and lifestyle factors: analysis of LIPIDOGRAM2015 and LIPIDOGEN2015 studies.

Krzemien P, Kasperczyk S, Banach M, Kasperczyk A, Dobrakowski M, Tomasik T Arch Med Sci. 2023; 19(5):1214-1227.

PMID: 37732061 PMC: 10507751. DOI: 10.5114/aoms/139313.

Perceived Stress and Prediction of Worse Disease Activity and Symptoms in a Multiracial, Multiethnic Systemic Lupus Erythematosus Cohort.

Patterson S, Trupin L, Hartogensis W, DeQuattro K, Lanata C, Gordon C Arthritis Care Res (Hoboken). 2022; 75(8):1681-1689.

PMID: 36537191 PMC: 10279800. DOI: 10.1002/acr.25076.

References

Syrigos K, Charalambopoulos A, Pliarchopoulou K, Varsamidakis N, Machairas A, Mandrekas D . The prognostic significance of autoantibodies against dsDNA in patients with colorectal adenocarcinoma. Anticancer Res. 2001; 20(6B):4351-3. View

Mooney L, Perera F, Van Bennekum A, Blaner W, Karkoszka J, Covey L . Gender differences in autoantibodies to oxidative DNA base damage in cigarette smokers. Cancer Epidemiol Biomarkers Prev. 2001; 10(6):641-8. View

Arbuckle M, James J, Kohlhase K, Rubertone M, Dennis G, Harley J . Development of anti-dsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus. Scand J Immunol. 2001; 54(1-2):211-9. DOI: 10.1046/j.1365-3083.2001.00959.x. View

Ghaussy N, Sibbitt Jr W, Qualls C . Cigarette smoking, alcohol consumption, and the risk of systemic lupus erythematosus: a case-control study. J Rheumatol. 2001; 28(11):2449-53. View

Vestergaard P, Rejnmark L, Weeke J, Hoeck H, Nielsen H, Rungby J . Smoking as a risk factor for Graves' disease, toxic nodular goiter, and autoimmune hypothyroidism. Thyroid. 2002; 12(1):69-75. DOI: 10.1089/105072502753451995. View

Ignat G, Rat A, Sychra J, Vo J, Varga J, Teodorescu M . Information on diagnosis and management of systemic lupus erythematosus derived from the routine measurement of 8 nuclear autoantibodies. J Rheumatol. 2003; 30(8):1761-9. View

Stolt P, Bengtsson C, Nordmark B, Lindblad S, Lundberg I, Klareskog L . Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis. 2003; 62(9):835-41. PMC: 1754669. DOI: 10.1136/ard.62.9.835. View

Riise T, Nortvedt M, Ascherio A . Smoking is a risk factor for multiple sclerosis. Neurology. 2003; 61(8):1122-4. DOI: 10.1212/01.wnl.0000081305.66687.d2. View

Costenbader K, Kim D, Peerzada J, Lockman S, Nobles-Knight D, Petri M . Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis. Arthritis Rheum. 2004; 50(3):849-57. DOI: 10.1002/art.20049. View

10.

Hung R, Boffetta P, Brennan P, Malaveille C, Gelatti U, Placidi D . Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk. Carcinogenesis. 2004; 25(6):973-8. DOI: 10.1093/carcin/bgh080. View

11.

Wu X, Zhao H, Suk R, Christiani D . Genetic susceptibility to tobacco-related cancer. Oncogene. 2004; 23(38):6500-23. DOI: 10.1038/sj.onc.1207811. View

12.

Tan E, Cohen A, Fries J, MASI A, McShane D, Rothfield N . The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982; 25(11):1271-7. DOI: 10.1002/art.1780251101. View

13.

Blount S, Griffiths H, Emery P, Lunec J . Reactive oxygen species modify human DNA, eliciting a more discriminating antigen for the diagnosis of systemic lupus erythematosus. Clin Exp Immunol. 1990; 81(3):384-9. PMC: 1534993. DOI: 10.1111/j.1365-2249.1990.tb05343.x. View

14.

Frenkel K, Karkoszka J, Kim E, Taioli E . Recognition of oxidized DNA bases by sera of patients with inflammatory diseases. Free Radic Biol Med. 1993; 14(5):483-94. DOI: 10.1016/0891-5849(93)90105-4. View

15.

Lunec J, Herbert K, Blount S, Griffiths H, Emery P . 8-Hydroxydeoxyguanosine. A marker of oxidative DNA damage in systemic lupus erythematosus. FEBS Lett. 1994; 348(2):131-8. DOI: 10.1016/0014-5793(94)00583-4. View

16.

Blount S, Lunec J, Griffiths H, Herbert K, Isenberg D . Binding of anti-DNA antibodies to oxidatively damaged DNA in spouses and relatives of patients with systemic lupus erythematosus. Immunol Lett. 1994; 41(2-3):135-8. DOI: 10.1016/0165-2478(94)90123-6. View

17.

Mooney L, Santella R, Covey L, Jeffrey A, Bigbee W, Randall M . Decline of DNA damage and other biomarkers in peripheral blood following smoking cessation. Cancer Epidemiol Biomarkers Prev. 1995; 4(6):627-34. View

18.

Petruzzelli S, Celi A, Pulera N, Baliva F, Viegi G, Carrozzi L . Serum antibodies to benzo(a)pyrene diol epoxide-DNA adducts in the general population: effects of air pollution, tobacco smoking, and family history of lung diseases. Cancer Res. 1998; 58(18):4122-6. View

19.

Jonsson T, Thorsteinsson J, Valdimarsson H . Does smoking stimulate rheumatoid factor production in non-rheumatic individuals?. APMIS. 1998; 106(10):970-4. DOI: 10.1111/j.1699-0463.1998.tb00247.x. View

20.

Shinozaki R, Inoue S, Choi K, Tatsuno T . Association of benzo[a]pyrene-diol-epoxide-deoxyribonucleic acid (BPDE-DNA) adduct level with aging in male smokers and nonsmokers. Arch Environ Health. 1999; 54(2):79-85. DOI: 10.1080/00039899909602240. View